Illumina takes on BGI in battle for Chinese NIPT market
Super-sequencing giant Illumina hopes to lock horns with Chinese rival BGI over the potentially highly lucrative internal market for non-invasive prenatal testing (NIPT).
Super-sequencing giant Illumina hopes to lock horns with Chinese rival BGI over the potentially highly lucrative internal market for non-invasive prenatal testing (NIPT).
Schizophrenia and bipolar research at the Broad Institute have received a major injection of funding from businessman Ted Stanley.
The UK Department of Health has said that plans to legalise ‘3-person IVF’ or mitochondrial transfer are moving forward.
A new genomics data partnership has received major funding from New York State in the US.
A Cambridge collaboration has yielded a new single-cell technique for mapping genome-wide epigenetic marking.
The new Science Minister, Greg Clark, has announced that all seven UK research councils, under the leadership of the Medical Research Council (MRC), will join forces to form a ’war cabinet’ to tackle antimicrobial resistance.
A study published recently in Nature Genetics reported that patients with variations in the TANC1 gene showed greater risk of side effects from late radiation-induced damage after radiotherapy for prostate cancer.
